Detalhe da pesquisa
1.
The Engineered Lysin, CF-370, is Active Against Antibiotic-Resistant Gram-Negative Pathogens In vitro and Synergizes with Meropenem in Experimental Pseudomonas aeruginosa Pneumonia.
J Infect Dis
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366561
2.
Exebacase Demonstrates In Vitro Synergy with a Broad Range of Antibiotics against both Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus.
Antimicrob Agents Chemother
; 64(2)2020 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31712212
3.
Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective Endocarditis.
Antimicrob Agents Chemother
; 63(10)2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31332073
4.
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.
Vaccine
; 28(2): 484-93, 2009 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19857446
5.
Development and preclinical evaluation of an alphavirus replicon vaccine for influenza.
Vaccine
; 25(48): 8180-9, 2007 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-17961878